SScience Read More Methylation-sensitive Cas9 can selectively target DNA in tumor cellsApril 18, 2026 Â CRISPR-Cas gene-editing tools have revolutionized the world of biotechnology and medicine. And each year, it seems, these…
SScience Read More A safer gene-editing tool shows promise for transthyretin amyloidosis treatmentJanuary 15, 2026 Genetic disorders occur due to alterations in the primary genetic material, deoxyribonucleic acid (DNA), of an organism. Transthyretin…
SScience Read More A precise tool to halt viral protein productionJanuary 8, 2026 Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to…
HHealth Read More One-time CRISPR therapy safely lowers cholesterol and triglycerides in early trialNovember 11, 2025 In a 15-patient, Phase 1 one, first-in-human trial, a one-time, CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol and…
HHealth Read More Study reveals acidic conditions as key to pancreatic cancer survivalOctober 10, 2025 Tumors are not a comfortable place to live: oxygen deficiency, nutrient scarcity, and the accumulation of sometimes harmful…